Product Images Advair Diskus
View Photos of Packaging, Labels & Appearance
- Fluticasone propionate chemical structure - advair diskus spl graphic 01
- Salmeterol xinafoate chemical structure - advair diskus spl graphic 02
- Figure 1. Mean Percent Change from Baseline in FEV1 in Subjects with Asthma Previously Treated with Either Inhaled Corticosteroids or Salmeterol (Trial 1) - advair diskus spl graphic 03
- S:\Project Files\A\Advair Diskus NDA 021077\Figures\advair-diskus-spl-graphic-04.jpg - advair diskus spl graphic 04
- Figure 3. Percent Change in Serial 12-Hour FEV1 in Subjects with Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Trial 1) - advair diskus spl graphic 05
- Figure 4. Predose FEV1: Mean Percent Change from Baseline in Subjects with Chronic Obstructive Pulmonary Disease - advair diskus spl graphic 06
- Figure 5. Two-Hour Postdose FEV1: Mean Percent Changes from Baseline over Time in Subjects with Chronic Obstructive Pulmonary Disease - advair diskus spl graphic 07
- Figure A - advair diskus spl graphic 08
- Figure B - advair diskus spl graphic 09
- Figure C - advair diskus spl graphic 10
- Figure D - advair diskus spl graphic 11
- Figure E - advair diskus spl graphic 12
- Figure F - advair diskus spl graphic 13
- Figure G - advair diskus spl graphic 14
- Figure H - advair diskus spl graphic 15
- Label Image - lbl500904502
Product Label Images
The following 16 images provide visual information about the product associated with Advair Diskus NDC 50090-4502 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Fluticasone propionate chemical structure - advair diskus spl graphic 01
Salmeterol xinafoate chemical structure - advair diskus spl graphic 02
Figure 1. Mean Percent Change from Baseline in FEV1 in Subjects with Asthma Previously Treated with Either Inhaled Corticosteroids or Salmeterol (Trial 1) - advair diskus spl graphic 03
Not available.*
S:\Project Files\A\Advair Diskus NDA 021077\Figures\advair-diskus-spl-graphic-04.jpg - advair diskus spl graphic 04
Figure 3. Percent Change in Serial 12-Hour FEV1 in Subjects with Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Trial 1) - advair diskus spl graphic 05
Figure 4. Predose FEV1: Mean Percent Change from Baseline in Subjects with Chronic Obstructive Pulmonary Disease - advair diskus spl graphic 06
Figure 5. Two-Hour Postdose FEV1: Mean Percent Changes from Baseline over Time in Subjects with Chronic Obstructive Pulmonary Disease - advair diskus spl graphic 07
Figure A - advair diskus spl graphic 08
Not available*
Figure B - advair diskus spl graphic 09
Figure C - advair diskus spl graphic 10
Figure D - advair diskus spl graphic 11
Figure E - advair diskus spl graphic 12
Figure F - advair diskus spl graphic 13
Figure G - advair diskus spl graphic 14
Figure H - advair diskus spl graphic 15
Label Image - lbl500904502
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
